Analyst · Revolution Medicines, Inc. (RVMD) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy26 analysts

Buy

Updated Aug 6, 2026

Total Analysts26

Strong Buy

1

Buy

21

Hold

1

Ratings

Updated Aug 6, 2026

Overall Rating

C-

DCF Score2.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$197.81

Median Target-26.66%

$145.08

Potential downside vs current price

DCF Value-99.56%

$0.88

Potential downside vs current price

Current Stock Price

$197.81

Median Target-26.66%

$145.08

Potential downside vs current price

DCF Value-99.56%

$0.88

Potential downside vs current price

Analyst Consensus

Buy26 analysts

Buy

Updated Aug 6, 2026

Total Analysts26

Strong Buy

1

Buy

21

Hold

1

Ratings

Updated Aug 6, 2026

Overall Rating

C-

DCF Score2.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$197.81

Median Target-26.66%

$145.08

Potential downside vs current price

DCF Value-99.56%

$0.88

Potential downside vs current price

Current Stock Price

$197.81

Median Target-26.66%

$145.08

Potential downside vs current price

DCF Value-99.56%

$0.88

Potential downside vs current price